Impact of the pandemic and concomitant COVID-19 on the management and outcomes of middle cerebral artery strokes : a nationwide registry-based study

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..

OBJECTIVES: To investigate the impact of the COVID-19 pandemic as well as concomitant COVID-19 itself on stroke care, focusing on middle cerebral artery (MCA) territory infarctions.

DESIGN: Registry-based study.

SETTING: We used the National Inpatient Sample (NIS) database, which covers a wide range of hospitals within the USA.

PARTICIPANTS: The NIS was queried for patients with MCA strokes between 2016 and 2020. In total, 35 231 patients were included.

OUTCOME MEASURES: Outcome measures were postprocedural complications, length of stays (LOSs), in-hospital mortality and non-routine discharge. Propensity score matching using all available baseline variables was performed to reduce confounders when comparing patients with and without concomitant COVID-19.

RESULTS: Mechanical thrombectomy (MT) was performed in 48.4%, intravenous thrombolysis (IVT) in 38.2%, and both MT and IVT (MT+IVT) in 13.4% of patients. A gradual increase in the use of MT and an opposite decrease in the use of IVT (p<0.001) was detected during the study period. Overall, 25.0% of all patients were admitted for MCA strokes during the pandemic period (2020), of these 209 (2.4%) were concomitantly diagnosed with COVID-19. Patients with MCA strokes and concomitant COVID-19 were significantly younger (64.9 vs 70.0; p<0.001), had significantly worse NIH Stroke Severity scores, and worse outcomes in terms of LOS (12.3 vs 8.2; p<0.001), in-hospital mortality (26.3% vs 9.8%; p<0.001) and non-routine discharge (84.2% vs 76.9%; p=0.013), as compared with those without COVID-19. After matching, only in-hospital mortality rates remained significantly higher in patients with COVID-19 (26.7% vs 8.5%; p<0.001). Additionally, patients with COVID-19 had higher rates of thromboembolic (12.3% vs 7.6%; p=0.035) and respiratory (11.3% vs 6.6%; p=0.029) complications.

CONCLUSIONS: Among patients with MCA stroke, those with concomitant COVID-19 were significantly younger and had higher stroke severity scores. They were more likely to experience thromboembolic and respiratory complications and in-hospital mortality compared with matched controls.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

BMJ open - 14(2024), 2 vom: 27. Feb., Seite e080738

Sprache:

Englisch

Beteiligte Personen:

Ghaith, Abdul Karim [VerfasserIn]
El-Hajj, Victor Gabriel [VerfasserIn]
Atallah, Elias [VerfasserIn]
Rios Zermeno, Jorge [VerfasserIn]
Ravindran, Krishnan [VerfasserIn]
Gharios, Maria [VerfasserIn]
Hoang, Harry [VerfasserIn]
Bydon, Mohamad [VerfasserIn]
Ohlsson, Marcus [VerfasserIn]
Elmi-Terander, Adrian [VerfasserIn]
Tawk, Rabih G [VerfasserIn]
Jabbour, Pascal [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Fibrinolytic Agents
Journal Article
Neurology
Stroke

Anmerkungen:

Date Completed 01.03.2024

Date Revised 01.03.2024

published: Electronic

Citation Status MEDLINE

doi:

10.1136/bmjopen-2023-080738

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369078934